Health-care companies rose amid generally strong earnings.

Haleon shares rose after the maker of over-the-counter health products, a GSK spinoff, posted growth in 2023 profit, and reiterated growth targets for 2024.

Viking Therapeutics gave back some of its gains, but has still more than doubled for the week, as Wall Street analysts said euphoria over its weight-loss drug was warranted. Shares of Danish rival Novo Nordisk slipped.

Write to Rob Curran at

(END) Dow Jones Newswires

02-29-24 1727ET